NL7404140A - - Google Patents

Info

Publication number
NL7404140A
NL7404140A NL7404140A NL7404140A NL7404140A NL 7404140 A NL7404140 A NL 7404140A NL 7404140 A NL7404140 A NL 7404140A NL 7404140 A NL7404140 A NL 7404140A NL 7404140 A NL7404140 A NL 7404140A
Authority
NL
Netherlands
Application number
NL7404140A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7404140A publication Critical patent/NL7404140A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NL7404140A 1973-04-11 1974-03-27 NL7404140A (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35022573A 1973-04-11 1973-04-11
US442276A US3925344A (en) 1973-04-11 1974-02-13 Plasma protein substitute

Publications (1)

Publication Number Publication Date
NL7404140A true NL7404140A (sv) 1974-10-15

Family

ID=26996533

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7404140A NL7404140A (sv) 1973-04-11 1974-03-27

Country Status (9)

Country Link
US (1) US3925344A (sv)
BR (1) BR7402876D0 (sv)
CA (1) CA1033721A (sv)
DE (1) DE2417619C2 (sv)
FR (1) FR2225171B1 (sv)
GB (1) GB1427903A (sv)
NL (1) NL7404140A (sv)
SE (1) SE429195B (sv)
SU (1) SU629854A3 (sv)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2607706A1 (de) * 1975-02-27 1976-09-09 Alza Corp Wasserloesliches, polymerisiertes haemoglobin
US5854210A (en) * 1995-04-10 1998-12-29 Baxter International Inc. Use of cross-linked hemoglobin in treating subarachnoid hemorrhage

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2449885C3 (de) * 1974-10-21 1980-04-30 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Herstellung von chemisch modifizierten haltbaren Hämoglobinpräparaten sowie das nach diesem Verfahren hergestellte modifizierte Hämoglobinpräparat
US4009267A (en) * 1975-09-09 1977-02-22 Diagnostic Data, Inc. Cross-linked orgotein
CA1055932A (en) * 1975-10-22 1979-06-05 Hematech Inc. Blood substitute based on hemoglobin
US4343715A (en) * 1980-10-10 1982-08-10 Duke University Immobilized hemoglobin, and processes for extracting oxygen from fluids using the same
US4427416A (en) 1980-10-10 1984-01-24 Duke University Processes for extracting oxygen from fluids using immobilized hemoglobin
US4473496A (en) * 1981-09-14 1984-09-25 The United States Of America As Represented By The Secretary Of The Army Intramolecularly crosslinked hemoglobin
DE3320752A1 (de) * 1983-06-09 1984-12-13 Wolfgang Prof. Dr.Dr. 6500 Mainz Barnikol Lumineszierende schichten zur verwendung in vorrichtungen zur bestimmung der sauerstoffkonzentration in gasen und dergleichen durch messung der lumineszensverringerung
DE3340592A1 (de) * 1983-11-10 1985-05-23 B. Braun Melsungen Ag, 3508 Melsungen Konjugate makromolekularer verbindungen an haemoglobine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
US4598064A (en) * 1984-06-27 1986-07-01 University Of Iowa Research Foundation Alpha-alpha cross-linked hemoglobins
USRE34271E (en) * 1984-06-27 1993-06-01 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
US4600531A (en) * 1984-06-27 1986-07-15 University Of Iowa Research Foundation Production of alpha-alpha cross-linked hemoglobins in high yield
US4584130A (en) * 1985-03-29 1986-04-22 University Of Maryland Intramolecularly cross-linked hemoglobin and method of preparation
US5955581A (en) * 1986-11-10 1999-09-21 Biopure Corporation Method for producing a stable polymerized hemoglobin blood-substitute
US5753616A (en) * 1986-11-10 1998-05-19 Biopure Corporation Method for producing a stable polymerized hemoglobin blood-substitute
US5189146A (en) * 1987-05-05 1993-02-23 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Pasteurizable, freeze-driable hemoglobin-based blood substitute
GB8710598D0 (en) * 1987-05-05 1987-06-10 Star Medical Diagnostics Ltd Hemoglobin based blood substitute
EP0302734B1 (en) * 1987-08-06 1993-10-20 Oxygenetics Inc. Continuous processes for modifying biologically active materials and the products therefrom
US5248766A (en) * 1990-08-17 1993-09-28 Baxter International Inc. Oxirane-modified hemoglobin based composition
JPH06502848A (ja) * 1990-11-29 1994-03-31 ジ・アップジョン・カンパニー イミドエステル架橋ヘモグロビン組成物
US5900477A (en) * 1992-01-30 1999-05-04 Baxter International, Inc. Use of hemoglobin in the treatment of hemorrhagic shock
US5334706A (en) * 1992-01-30 1994-08-02 Baxter International Administration of low dose hemoglobin to increase perfusion
US5980954A (en) 1992-02-07 1999-11-09 Vasogen Ireland Limited Treatment of autoimmune diseases
GB9617611D0 (en) * 1996-08-22 1996-10-02 Vasogen Inc Treatment of autoimmune disease
US6669965B2 (en) 1992-02-07 2003-12-30 Vasogen Ireland Limited Method of treating atherosclerosis
US5591457A (en) * 1992-02-07 1997-01-07 Vasogen Inc Method of inhibiting the aggregation of blood platelets and stimulating the immune systems of a human
DE4418973A1 (de) * 1994-05-31 1995-12-14 Barnikol Wolfgang Verfahren zur Herstellung molekular-einheitlicher hyperpolymerer Hämoglobine
US5783214A (en) * 1994-06-13 1998-07-21 Buford Biomedical, Inc. Bio-erodible matrix for the controlled release of medicinals
EP0854151A1 (de) 1997-01-20 1998-07-22 SanguiBioTech AG Verfahren zur Gewinnung einheitlicher Fraktionen hyperpolymerer Hämoglobine
US6054427A (en) * 1997-02-28 2000-04-25 The Regents Of The University Of California Methods and compositions for optimization of oxygen transport by cell-free systems
US5814601A (en) * 1997-02-28 1998-09-29 The Regents Of The University Of California Methods and compositions for optimization of oxygen transport by cell-free systems
CA2233725A1 (en) * 1998-03-31 1999-09-30 Hemosol Inc. Hemoglobin-hydroxyethyl starch complexes
US20050164915A1 (en) * 2002-04-01 2005-07-28 Sangart, Inc. Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
WO2003059286A2 (en) * 2002-01-11 2003-07-24 Sangart, Inc. Methods and compositions for oxygen transport comprising modified hemoglobin in plasma
EP1894573A3 (en) 2002-01-11 2013-06-12 Sangart, Inc. Methods and compositions for oxygen transport comprising a high oxygen affinity
AU2003202941A1 (en) * 2002-01-11 2003-07-30 Sangart, Inc. Methods and compositions for oxygen transport comprising an oxygen carrier and a crystalloid in hypertonic solution
US20030153491A1 (en) * 2002-01-11 2003-08-14 Winslow Robert M. Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
JP3912206B2 (ja) * 2002-07-05 2007-05-09 株式会社日立製作所 筒内直接燃料噴射装置用燃料ポンプ
US7135554B1 (en) * 2004-01-27 2006-11-14 Biopure Corporation Method of forming a polymerized hemoglobin solution from stabilized hemoglobin
ATE478674T1 (de) 2004-08-31 2010-09-15 Sangart Inc Verfahren zur verbesserung der hämodynamischen stabilität mit sauerstoff-tragenden zusammensetzungen
US8273857B2 (en) * 2009-09-22 2012-09-25 Jen-Chang Hsia Compositions and methods of use of neurovascular protective multifunctional polynitroxylated pegylated carboxy hemoglobins for transfusion and critical care medicine
US8084581B1 (en) * 2011-04-29 2011-12-27 Bing Lou Wong Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus
EP2991627B1 (en) 2013-05-03 2018-09-05 Washington University Blood substitute composition and method of use
RU2749266C1 (ru) * 2020-02-10 2021-06-07 Богдан Иванович Асатуров Способ получения биоплазмозаменителя гемодинамического действия

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE945650C (de) * 1952-01-24 1956-07-12 Charles B Knox Gelatine Co Inc Verfahren zur Herstellung von als Blutplasmastreckmittel dienenden serologisch vertraeglichen Proteinderivaten
SE343210B (sv) * 1967-12-20 1972-03-06 Pharmacia Ab

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2607706A1 (de) * 1975-02-27 1976-09-09 Alza Corp Wasserloesliches, polymerisiertes haemoglobin
US5854210A (en) * 1995-04-10 1998-12-29 Baxter International Inc. Use of cross-linked hemoglobin in treating subarachnoid hemorrhage

Also Published As

Publication number Publication date
DE2417619A1 (de) 1974-10-31
FR2225171A1 (sv) 1974-11-08
SU629854A3 (ru) 1978-10-25
SE429195B (sv) 1983-08-22
CA1033721A (en) 1978-06-27
FR2225171B1 (sv) 1977-08-12
DE2417619C2 (de) 1986-10-23
GB1427903A (en) 1976-03-10
BR7402876D0 (pt) 1974-12-03
US3925344A (en) 1975-12-09

Similar Documents

Publication Publication Date Title
AR201758A1 (sv)
AU476761B2 (sv)
AU465372B2 (sv)
AR201235Q (sv)
AR201231Q (sv)
AU474593B2 (sv)
AU474511B2 (sv)
AU474838B2 (sv)
AU471343B2 (sv)
AU465453B2 (sv)
AU465434B2 (sv)
AU450229B2 (sv)
AU476714B2 (sv)
AR201229Q (sv)
AU472848B2 (sv)
AU476696B2 (sv)
AU466283B2 (sv)
AR199451A1 (sv)
FR2234443B1 (sv)
AU477823B2 (sv)
AR200885A1 (sv)
AU476873B1 (sv)
AR195311A1 (sv)
AR195948A1 (sv)
AU461342B2 (sv)

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
A85 Still pending on 85-01-01
BV The patent application has lapsed